OptiBiotix Health signs distribution deal for cholesterol supplement covering Australia, New Zealand, Indonesia and Thailand
Leading this latest leg of the international expansion will be Actial Farmaceutica
Company
OptiBiotix Health PLC
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 4 of 29
OptiBiotix Health launches new fibres, minerals blend for gut microbiome health
WellBiome is an evolution of SlimBiome, a functional ingredient sold in more than 70 countries formulated to support weight loss and weight management
OptiBiotix Health business inks UK distribution deal for two key products
The company has teamed up with Cambridge Commodities
OptiBiotix looking to extend its reach into new application areas
The group’s commercial plans for 2020 are centred on extending its reach into new application areas, including hypertension, immune and cognitive health
OptiBiotix Health signs license agreement for SlimBiome trademark with Bobbi Brown's Evolution_18 and related launch of fibre gummies
Brown who is known for turning a simple makeup line, Bobbi Brown Essentials, into a billion-dollar global brand with Estée Lauder Companies
OptiBiotix sees partnership agreements deliver strong revenue growth
“We anticipate further revenue growth in 2020 as existing deals contribute to full-year revenues," said Stephen O’Hara, the group's chief executive officer
OptiBiotix recognised as "key player" in global human microbiome market
The data from Market Study Report said a "growing sedentary lifestyle, increasing incidence of diabetes and chronic diseases globally" will facilitate market growth over the next four years
OptiBiotix signs exclusive distribution deal with MAXCARE for SlimBiome in Taiwan
The group said MAXCARE was “well placed to educate customers on the benefits and functionality SlimBiome can provide”
OptiBiotix Health enters into distribution agreement covering China and Hong Kong
The agreement grants Pierce exclusive rights to import and commercialise OptiBiotix's SlimBiome weight management ingredient and LPLDL, its cholesterol-lowering probiotic, in China and Hong Kong
OptiBiotix Health signs deal with Smart For Life which will see launch of cookies containing SlimBiome in the USA and Canada
The life sciences group, which is developing compounds to tackle obesity, high cholesterol, diabetes and skincare, said the license is contingent on an annual minimum order quantity and the first order within thirty days of signing the agre
OptiBiotix raises £1mln to scale up and expand product ranges internationally
The money will also be used to expand awareness and presence of the company's existing products in the US market
OptiBiotix agrees contract manufacturing deal with French supplements and nutrition group
The move follows on from a tie-up last week with Denmark’s Fipros, which will produce food additive SlimBiome under license for distribution across the EU.
OptiBiotix ties up contract manufacturing deal with a Danish company
It said this latest commercial accord de-risked the business in the event of a hard Brexit, providing a source of product supply within the EU
Archive
Proactive news snapshot: Gfinity, Bango, FastForward Innovations UPDATE …
A glance at some of the day's highlights from the Proactive Investors newswire
OptiBiotix soars as it inks licence agreement for OptiBiome with Australian group OptiPharm
The deal will grant OptiPharm exclusive use of the OptiBiome brand in over 20 markets including Australia and North America
OptiBiotix Health extends distribution footprint for consumer weight management product with enhanced deal
Its agreement with a distributor called Extensor Robert Buczek to a further 15 Eastern European and Central Asian countries
OptiBiotix Health gains further commercial traction with Gulf states distribution deal
It has inked a one-year deal with Lebanon-based Prosperous Pharma
OptiBiotix Health strikes new deal in Bulgaria
Velinoff Pharma will promote and distribute the CholBiome and CholBiomeX3 brands, which contain the company’s LPLDL probiotic bacteria strain
OptiBiotix Health modifies and extends deal with partner Sacco
Instead of the original profit-sharing arrangement, it now becomes a manufacture and supply deal with pricing discounts for increasing sales volumes
OptiBiotix Health updates on commercial initiatives
Chief among them was the complete evaluation of the ingredients of weight management line SlimBiome to ensure they are generally recognised as safe per US Code 21 CFR 170.30